Clinical Trials Directory

Trials / Completed

CompletedNCT03414463

Training to Reconnect With Emotional Awareness Therapy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
44 (actual)
Sponsor
Indiana University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To decrease emotional self-awareness deficits and improve emotional self-regulation, particularly anxiety, anger, depression, and positive affect, through the treatment of alexithymia.

Detailed description

Phase II randomized, Waitlist Control (WLC) trial with 3-month follow-up to further establish proof of concept and early efficacy of TREAT (1:1 alexithymia treatment) for post-TBI alexithymia. It is anticipated that our target sample size is 44. The purpose of this study is to examine differences in post-treatment self-reported alexithymia and emotional self-awareness in participants with TBI randomized to TREAT or WLC. In addition to examining the differences in post-treatment self-reported emotion regulation (general), anxiety, anger, depression, positive affect (PA), global emotional function and quality of life in participants with TBI randomized to TREAT or WLC.

Conditions

Interventions

TypeNameDescription
BEHAVIORALTREATA 4-week one-to-one intervention between the clinical RA (cRA) and participant. Comprised of eight sessions, it involves psycho-educational lessons and skill-building exercises to achieve objectives based on the characteristics of alexithymia.

Timeline

Start date
2018-05-08
Primary completion
2023-11-10
Completion
2023-11-14
First posted
2018-01-30
Last updated
2024-05-20

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03414463. Inclusion in this directory is not an endorsement.